CME Group Inc.

CME Group Inc. (CME) Market Cap

CME Group Inc. has a market capitalization of $96.29B.

Price: $267.79

0.57 (0.21%)

Market Cap: 96.29B

NASDAQ · time unavailable

CEO: Terrence A. Duffy

Sector: Financial Services

Industry: Financial - Data & Stock Exchanges

IPO Date: 2002-12-06

Website: https://www.cmegroup.com

CME Group Inc. (CME) - Company Information

Market Cap: 96.29B|Sector: Financial Services

Company Profile

CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the verification, settlement, and guarantee of futures, options, and cleared swap agreements traded across its venues. It also offers services for transaction processing and risk mitigation. Furthermore, the organization provides diverse market data services, encompassing both real-time and historical data feeds. Its wide-ranging client base consists of professional traders, financial institutions, both institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. Founded in Chicago, Illinois, in 1898, the enterprise was formerly known as Chicago Mercantile Exchange Holdings Inc. before rebranding as CME Group Inc. in July 2007.

Analyst Sentiment

67%
Buy

From 17 Active Polls

1Y Forecast: $304.33

▲ +13.6% Potential Upside

Consensus Target Metrics

Low Bound

$260

Median

$309

High Bound

$330

Average

$304

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$304.33
▲ +13.65% Upside
Low Target
$260.00
-3% Risk
Median Target
$309.00
15% Mid
High Target
$330.00
23% Max
Consensus
Hold
15 / 37 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Period EndingTrailing 12MJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024
Market Cap ($M)96,29279,500106,12598,20997,17599,12395,40283,46179,302
Enterprise Value ($M)97,57280,780107,15797,54298,149100,56297,41683,99780,407
Price to Earnings Ratio (P/E)22.6019.3022.7221.0127.1324.5225.2224.1921.98
Price/Earnings-to-Growth Ratio (PEG)1.622.918.103.296.49
Price to Sales Ratio (P/S)14.2246.5956.4559.5763.2058.5858.0954.7250.05
Price to Book Ratio (P/B)3.643.003.993.423.453.573.533.152.81
Price to Free Cash Flow Ratio (P/FCF)22.8686.0985.7289.17102.3295.3086.5484.1681.49
Enterprise Value to Sales (EV/Sales)47.3457.0059.1663.8359.4359.3255.0750.75
Enterprise Value to EBITDA (EV/EBITDA)18.1896.8165.4361.3575.2968.9971.1668.8161.80
Debt to Equity Ratio0.240.130.130.130.120.120.130.130.12

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 CME GROUP INC CLASS A (CME) — Investment Overview

🧩 Business Model Overview

CME Group operates a regulated marketplace and clearing infrastructure for exchange-traded derivatives and related financial products. The value chain is straightforward: participants trade standardized futures and options on CME’s electronic and open-outcry markets, while CME’s clearinghouse acts as the central counterparty to manage counterparty credit risk through performance bond (initial and variation margin) mechanics and rigorous risk controls.

This structure creates a two-sided ecosystem—liquidity is generated by hedgers, speculators, brokers, and end users, and it is supported by CME’s clearing and risk management capabilities. Revenue is earned not only from trading activity, but also from clearing and related services that remain tied to outstanding market positions and continued participation in CME-listed contracts.

💰 Revenue Streams & Monetisation Model

  • Transaction-based revenue: Fees from futures and options trading, generally linked to activity levels, contract mix, and the average execution environment (electronic vs. other venues).
  • Clearing and clearing-related revenue: Charges associated with clearing services, including clearing fees and other services connected to risk management and settlement processes.
  • Data and technology services: Market data and connectivity-related revenues that scale with global usage and demand for real-time pricing and analytics.
  • Other recurring revenues: Service components and licensing that tend to be structurally more durable than pure transaction volumes.

Margin drivers are primarily (1) mix shift toward higher-value products (by asset class and contract design), (2) operating leverage from technology scale and shared infrastructure, and (3) the durability of clearing relationships once a participant integrates CME-listed contracts into their hedging workflows.

🧠 Competitive Advantages & Market Positioning

Primary moat: network effects in liquidity + switching costs in standardized risk transfer. Derivatives markets are difficult to replicate at scale because liquidity begets liquidity: tighter spreads, deeper order books, and reliable execution improve outcomes for end users. Over time, participants align hedging and margin frameworks around the most liquid contracts, reinforcing participation patterns and reducing incentive to migrate.

  • Liquidity network effects: As trading volume and open interest concentrate in specific contracts, execution quality and market depth tend to improve, attracting additional participation.
  • Switching costs: Integrating new venues and clearing pathways involves operational, legal, connectivity, and hedging workflow changes. Contract-level standardization and established reference pricing further raise the cost of switching.
  • Regulatory and credibility moat: Clearinghouse performance depends on robust risk models, margining discipline, and operational resilience under stress. The credibility of risk controls can take years to build and is constrained by regulatory frameworks.
  • Cost advantages: CME’s scale in clearing operations and technology reduces unit costs for processing trades and managing collateral.

Competitive benchmarking: The major exchange/clearing competitors include Intercontinental Exchange (ICE), Nasdaq (including derivatives and clearing ecosystems), and Euronext (Euronext Derivatives, with clearing partners). These peers compete for product listings, liquidity, and trading participation.

CME’s positioning emphasizes a broad, multi-asset derivatives suite with deep global liquidity across rate, equity index, commodity, and FX-related contracts, whereas rivals often anchor around regional strengths and differentiated product offerings. The critical competitive difference tends to be which venue sustains the deepest liquidity and most trusted clearing outcomes for each contract category.

🚀 Multi-Year Growth Drivers

  • Hedging demand from volatility and macro dispersion: Uncertainty across rates, energy, agricultural inputs, and equity exposures supports persistent demand for standardized hedges.
  • Product and contract expansion within existing ecosystems: Launching new contract specifications, rolling products, and refining settlement characteristics can extend participation without requiring wholesale changes to the clearing platform.
  • Electronic trading penetration: Growth in algorithmic and institutional electronic execution increases throughput and improves the addressability of global participants.
  • Regulatory-driven central clearing adoption: Market structure rules that favor central clearing can support clearing volumes and sustain the strategic importance of clearinghouses.
  • Data and connectivity tailwinds: Increased use of derivatives pricing in risk systems, execution algorithms, and enterprise analytics supports recurring market data demand.

Over a 5–10 year horizon, the TAM is best viewed through the lens of (1) the expanding universe of hedgable exposures and (2) the portion of those exposures that migrate toward transparent, standardized derivatives cleared through central counterparties. CME’s advantage is that it participates in both the trading and clearing layers, enabling it to capture value throughout the risk transfer lifecycle.

⚠ Risk Factors to Monitor

  • Regulatory and capital framework changes: Modifications to margining, clearing rules, or market structure mandates can affect economics and participant behavior.
  • Liquidity migration and competitive product cycles: Competitors may attract volume through new listings or more favorable contract designs, potentially pressuring execution quality and fee economics.
  • Concentration of operational and technology risk: Exchanges and clearinghouses rely on resilient systems; outages, cybersecurity incidents, or model errors can have outsized consequences.
  • Model and credit stress assumptions: Clearing performance depends on the adequacy of risk models, collateral haircuts, and recovery planning under extreme market conditions.
  • Interoperability and integration costs for participants: If participant workflows shift toward alternative venues or OTC-to-venue transitions with different mechanics, CME must maintain strong integration and product relevance.

📊 Valuation & Market View

Markets typically value exchange-clearing businesses based on the durability of earnings and operating leverage, commonly referencing EV/EBITDA-style frameworks rather than asset-growth metrics used for banks or insurers. Key variables that move valuation expectations include: (1) resilience of volumes and fee rates across market cycles, (2) mix of higher-margin data and clearing services, (3) the stability of clearing economics and risk-management outcomes, and (4) evidence of sustained product adoption and liquidity retention.

Because CME’s economics combine transaction-linked revenue with service components that benefit from scale and recurring usage, valuation tends to reward clarity around long-term growth in cleared volumes, product depth, and technology-led efficiency.

🔍 Investment Takeaway

CME Group’s long-term investment case rests on structural advantages in liquidity networks and clearing credibility, reinforced by participant switching costs embedded in trading and hedging workflows. With a scaled clearinghouse platform and a multi-asset derivatives marketplace, CME is positioned to compound through persistent hedging demand, continued electronic trading expansion, and ongoing regulatory support for central clearing—while managing key risks tied to regulation, technology resilience, and competitive liquidity dynamics.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for CME.

kitco.com2026-07-28

$60 million traded during inaugural weekend in the CME's 24/7 gold contract

Geopolitical uncertainty isn't taking weekends off, and neither are investors, as they embrace CME Group's 24/7 one-ounce gold contract.

zacks.com2026-07-27

4 Securities & Exchanges Stocks to Watch Despite Intense Competition

Zacks Securities and Exchanges industry players like CME, ICE, NDAQ and CBOE gain from rising crypto adoption, a higher non-trading revenue base and tech investments. However, competition remains a drag.

prnewswire.com2026-07-27

Traders Drive Strong Demand in First Weekend of CME Group's 24/7 Gold Futures

/PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced that nearly 15,000 1-Ounce Gold futures contracts traded during the

barrons.com2026-07-27

The New Way to Bet Big on Hot Stocks

The CME's new futures contracts let investors make magnified wagers on individual stocks—and on margin.

cnbc.com2026-07-27

CME launches single stock futures enabling investors to trade SpaceX, Micron 23 hours a day

CME Group launched cash-settled single-stock futures on 55 U.S. equities, along with micro-sized contracts on 22 names. The contracts trade on CME's Globex platform from Sunday evening through Friday afternoon, with a one-hour daily maintenance break.

fool.com2026-07-27

If I Only Had $500 to Invest, This Is the ETF I'd Buy Right Now

This value ETF offers a great value for investors right now.

seekingalpha.com2026-07-26

America's Most Powerful Banker Just Confirmed It: I Want These 5 Stocks, Not The Market

I prioritize a TOLL+M investment model—tangible assets, oligopoly advantages, low incremental CapEx, durable cash flows, and macro tailwinds—to build resilient portfolios. Jamie Dimon highlights that even with 2% inflation, 10-year yields should remain above 4.0-4.5% due to risk premiums, supporting my 'run-it-hot' thesis. The S&P 500 prices in a 'good outcome' with little margin of safety; I see greater opportunity in selective stock picking over broad index exposure.

defenseworld.net2026-07-24

CME Group Q2 Earnings Call Highlights

CME Group (NASDAQ: CME) reported record second-quarter revenue and near-record trading activity, while executives used much of the company's second-quarter 2026 earnings call to address investor questions about perpetual futures and outline a slate of new product launches. Chairman and CEO Terry Duffy said second-quarter average daily volume was 29.8 million contracts, the second-highest second quarter

seekingalpha.com2026-07-23

CME Group: Q2 Earnings Results Lead To A Rating Upgrade

CME Group has underperformed the S&P 500, declining nearly 12% over the past 11 months. CME delivered solid Q2 2026 results, with EPS of $2.99 and revenue of $1.71B, both of which beat analysts' expectations. Market Data revenue surged more than 20% compared to the same period a year ago.

seekingalpha.com2026-07-23

CME Group: Quality Growth With A Defensive Profile

CME Group is rated Buy, supported by record results and a resilient, defensible futures franchise. CME's moat is anchored in open interest and margin efficiencies, not just market share, insulating it from FMX's cash bond competition. Three underappreciated growth drivers: Treasury clearing, retail expansion, and crypto, are poised to fuel future compounding.

seekingalpha.com2026-07-23

CME Group's Strong Quarter Still Supports A Hold

CME Group maintains strong core performance, posting record Q2 revenue and robust margins, yet the stock remains range-bound and fully valued. Q2 2026 highlights include $2.99 non-GAAP EPS, $1.71B revenue, 69.5% adjusted operating margin, and resilient trading volumes across key product lines. Capital return remains aggressive with $1.2B distributed via dividends and buybacks, backed by a strong balance sheet and disciplined expense management.

reuters.com2026-07-22

CME profit tops estimates, CEO says 'perps' chatter overshadows results

CME Group beat Wall Street's second-quarter profit estimates on Wednesday, fueled by ​strong hedging demand, sending the derivatives exchange's shares up 6.1%.

seekingalpha.com2026-07-22

CME Group Inc. (CME) Q2 2026 Earnings Call Transcript

CME Group Inc. (CME) Q2 2026 Earnings Call Transcript

seekingalpha.com2026-07-22

Nomura Core Equity Fund Q2 2026 Portfolio Review

Seagate Technology shares continued to advance as demand for high-capacity storage tied to AI data-center buildouts supported further positive earnings revisions. On balance, the Fund's artificial intelligence positioning was a net positive contributor to relative performance during the quarter. We added the Humana position on the view that earnings are at a cyclical trough, with MA margins currently depressed, in some cases negative, as elevated medical cost trends have outpaced premium growth across the industry.

zacks.com2026-07-22

CME Q2 Earnings Beat Estimates on Record Market Data Growth

CME Group beats Q2 estimates as record market data revenues and resilient trading activity lift results, while expanding its product lineup.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"CME (Q2’26, ended 2026-06-30) delivered Revenue of $1.706B and Net Income of $1.042B, with diluted EPS of $2.88. QoQ, revenue declined -9.3% (from $1.880B in Q1’26) and net income declined -9.7% (from $1.154B). YoY, revenue rose +0.9% (vs. $1.692B in Q2’25) and net income increased +2.9% (vs. $1.012B). Profitability remains very strong in absolute terms but softened sequentially: net margin slipped to 61.1% from 61.4% QoQ, while gross margin compressed meaningfully to 69.2% from 88.1% QoQ (suggesting mix/timing effects in reported cost of revenue). Despite the margin giveback, operating income remained high at $1.107B and EPS stayed elevated. Cash flow data for 2026-06-30 is not populated (reported as zero), so cash-flow quality is inferred cautiously using prior quarters: CME historically converts earnings to operating cash flow robustly and returns capital via buybacks and dividends. Balance sheet resilience is solid with total assets of $194.7B and equity of $26.5B; leverage is low (net debt ~$1.28B). On shareholder returns, the stock is up +10.05% over 1Y (below the >20% momentum threshold), and the dividend yield is ~0.59%. Analysts’ consensus target is $304.33 vs. ~$287.65 current (~+5.9% upside)."

Revenue Growth

Positive

Revenue was $1.706B in Q2’26. QoQ: -9.3% (vs. Q1’26). YoY: +0.9% (vs. Q2’25), indicating stable demand but less sequential momentum.

Profitability

Positive

Net margin edged down to 61.1% from 61.4% QoQ; gross margin fell to 69.2% from 88.1% QoQ (likely timing/mix). YoY net income grew +2.9%, supporting EPS resilience (diluted EPS $2.88).

Cash Flow Quality

Neutral

Q2’26 cash flow fields are reported as zero, limiting validation of cash conversion for the latest quarter. Based on prior quarters, CME has demonstrated strong operating cash generation and capital returns, but current-quarter cash metrics are not reliable.

Leverage & Balance Sheet

Good

Total assets were $194.7B with equity of $26.5B. Leverage appears conservative with net debt of ~$1.28B and total debt ~$3.42B; equity is broadly stable QoQ.

Shareholder Returns

Positive

1Y price change is +10.05% (no strong momentum premium). Dividend yield is ~0.59%, and historical patterns suggest meaningful buybacks/dividends, but the latest-quarter cashflow is not available to quantify buybacks here.

Analyst Sentiment & Valuation

Positive

Consensus target is $304.33 vs. ~$287.65 current (~+5.9% upside). High-quality business supports valuation, but upside appears modest.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

CME delivered a strong Q2 2026 with revenue above $1.7B (+1% YoY) and record quarterly revenue, alongside market data strength (+20% to $238M) and solid profitability (69.5% adjusted operating margin; $2.99 adjusted EPS, +1% YoY). Operating momentum was reinforced by volume/open-interest positioning: 29.8M average daily contracts, open interest up 8% YoY and 16% YTD, and July-to-date volume tracking +18% YoY. Capital return was substantial ($1.2B total: $695M buybacks and $468M dividends). The Q&A focus centered on perpetual futures. Management provided firm institutional-demand evidence, repeatedly arguing perps’ funding/auto-liquidation mechanics and lack of price/time certainty make them unsuitable for the 94% institutional mix, despite some retail interest narratives. Management also reiterated a high-confidence innovation roadmap: 24/7 crypto success, 24/7 gold launch, Single Stock futures next week, Compute Futures with Silicon Data (NVIDIA H100 GPU rental index), and Treasury Link in Q4—while highlighting perceived regulatory inconsistencies around 24/7 approvals.

AI IconGrowth Catalysts

  • 24/7 trading of crypto futures; $1.5B+ traded over first eight weekends (as cited by management)
  • Launching 24/7 trading of one-ounce gold contract this weekend
  • Single Stock futures launch next week/next Monday to simplify directional trading with exceptional capital efficiency
  • Compute Futures reintroduced later this year with Silicon Data pricing indices (first daily benchmark tracking spot hourly rental cost of NVIDIA H100 GPUs)
  • Treasury Link planned for Q4 2026 to link U.S. Treasury futures with cash treasury liquidity pools

Business Development

  • Silicon Data as price reporting agency/partner for Compute Futures (NVIDIA H100 GPU rental index)
  • Partnership references for index IP: S&P Global (equity index intellectual property exclusivity concept), plus agreements acknowledged with Nasdaq and Russell

AI IconFinancial Highlights

  • Revenue: over $1.7B, up 1% YoY; record for second quarter revenue and second highest quarterly revenue behind Q1 2026
  • Average rate per contract: $0.678, up $0.026 vs Q1 2026
  • Market data revenue: up 20% to $238M; 33 consecutive quarters of YoY market data growth; 8 straight quarters of record market data revenue
  • Adjusted operating income: $1.2B; 69.5% adjusted operating margin
  • Adjusted net income and adjusted diluted EPS: $1.1B and $2.99 per share, respectively; EPS +1% vs Q2 2025
  • Adjusted net income margin: 63.4%
  • Capital return: $1.2B returned to shareholders; $468M regular dividends and $695M share repurchases

AI IconCapital Funding

  • Share repurchases: $695M during the quarter
  • Dividends: $468M regular quarterly dividends
  • Total shareholder returns: $1.2B during Q2

AI IconStrategy & Ops

  • 7/24/7 rollout: crypto futures 24/7 successful; metals 24/7 starts this weekend (one-ounce gold)
  • Product cadence: Single Stock futures next week/next Monday; Compute Futures later this year; Treasury Link in Q4
  • Perpetual futures stance reinforced: CME emphasized it has capability to launch but is not seeing customer demand from institutional participants

AI IconMarket Outlook

  • Q3 early: July-to-date tracking 18% ahead of last year (volume commentary)
  • Second half: management expects continued momentum given strong demand for risk management products

AI IconRisks & Headwinds

  • Regulatory risk/processing inconsistency: CFTC stayed 24/7 crude oil contract (reported by analyst prompt); management criticized perceived differences vs 24/7 gold go-ahead and raised concerns about manipulation susceptibility for some stayed/unstayed contracts
  • Product demand risk: management repeatedly stated institutional customers do not want perpetual futures due to inability to risk manage hedges (no price/time certainty; funding-rate/auto-liquidation dynamics deemed unsuitable)
  • Competitive displacement risk: Kalshi cited as launching a Bitcoin perp with much smaller scale (Kalshi $270M/day vs CME $4.5B–$6.5B/day; $10M open interest vs CME $9B–$10B average daily open interest), implying CME expects limited traction but still faces retail narrative risk

Q&A: Analyst Interest

  • Perpetual futures demand (especially retail) vs institutional needs: Management described extensive outreach to top-tier commercial institutions and stated they “do not want this product,” cannot risk manage leveraged spot-like perps with funding-rate and automated liquidations, and asserted retail total cost (fee plus funding) is typically “sevenfold” higher than CME execution costs.
  • Compute Futures demand and differentiation: Management framed Compute Futures as a daily benchmark for spot hourly NVIDIA H100 GPU rental cost, partnering with Silicon Data as the price reporting agency. They highlighted price certainty/curves for data-center input cost risk, procurement planning/budgeting, and expanded hedge usage across commodities and AI capex exposures.
  • CFTC approach to 24/7 product approvals and regulatory read-through: Management addressed stay vs go-forward filings by discussing CFTC Regulation 40.2 self-certification vs 40.3 full review, asserting CME filed appropriate paths for the small oil contract, was surprised by some other approvals, and suggested concerns about manipulation susceptibility and policing U.S. participants in 24/7 markets.

Sentiment: MIXED

Note: This summary was synthesized by AI from the CME Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for CME.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (CME)

© 2026 Stock Market Info — CME Group Inc. (CME) Financial Profile